Ladenburg Thalmann Financial Services’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $51K | Hold |
8,538
| – | – | ﹤0.01% | 3524 |
|
|
2019
Q3 | $65K | Sell |
8,538
-1,895
| -18% | -$14.4K | ﹤0.01% | 3252 |
|
|
2019
Q2 | $143K | Sell |
10,433
-950
| -8% | -$13K | ﹤0.01% | 2710 |
|
|
2019
Q1 | $62K | Buy |
11,383
+4,220
| +59% | +$23K | ﹤0.01% | 3263 |
|
|
2018
Q4 | $22K | Sell |
7,163
-625
| -8% | -$1.92K | ﹤0.01% | 3831 |
|
|
2018
Q3 | $64K | Sell |
7,788
-977
| -11% | -$8.03K | ﹤0.01% | 3152 |
|
|
2018
Q2 | $76K | Hold |
8,765
| – | – | ﹤0.01% | 2954 |
|
|
2018
Q1 | $76K | Sell |
8,765
-59
| -0.7% | -$512 | ﹤0.01% | 2954 |
|
|
2017
Q4 | $110K | Hold |
8,824
| – | – | ﹤0.01% | 2661 |
|
|
2017
Q3 | $74K | Buy |
8,824
+7,677
| +669% | +$64.4K | ﹤0.01% | 2806 |
|
|
2017
Q2 | $19K | Sell |
1,147
-111
| -9% | -$1.84K | ﹤0.01% | 3665 |
|
|
2017
Q1 | $25K | Buy |
1,258
+1,158
| +1,158% | +$23K | ﹤0.01% | 3419 |
|
|
2016
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 4569 |
|
|
2016
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 4679 |
|
|
2016
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 4640 |
|
|
2016
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 4585 |
|
|
2015
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 4571 |
|
|
2015
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 4483 |
|